By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The second day of the UBS Global Life Sciences Conference in New York featured several life science tools and molecular diagnostics companies making their pitches to the investor community.

Below are capsules from their presentations and breakout sessions.

Cepheid

Cepheid CFO Andrew Miller provided investors with an update on the firm's ambitious plans for rolling out new molecular tests over the next five years.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times Magazine writes that proteomics might be better poised than genomics to say when someone is falling ill.

Bloomberg profiles IndieBio, a startup incubator for the life sciences.

In an editorial, Nature calls for the end to the exploitation of foreign postdocs.

In Nucleic Acids Research this week: collection of epigenome-wide association study data, updated BloodSpot database, and more.